FTC Targets 'Illusory Systems' in Deception Deal
Published Date: 12/19/2025
Notice
Summary
Illusory Systems, Inc. is facing charges for unfair or tricky business practices, and the FTC wants to settle things with a new agreement that stops these actions. People can share their thoughts on this deal until January 20, 2026. If approved, Illusory Systems will have to change how they operate, protecting customers and keeping things fair—no fines mentioned, but big changes ahead!
Analyzed Economic Effects
6 provisions identified: 5 benefits, 1 costs, 0 mixed.
Major hack left users with huge losses
The complaint says hackers exploited a vulnerability in August 2022 and took virtually all assets from the token bridge—about $186 million—leaving users with losses that exceeded $100 million. This describes the scale of consumer financial harm tied to Illusory Systems' service.
Order requires return of recovered assets to users
Part VI of the proposed order requires Illusory Systems to return recovered assets to users. If the order is finalized, users would receive any assets the company recovers that relate to the August 2022 incident.
Must implement a comprehensive security program
Part II requires Illusory Systems to establish, implement, and maintain a comprehensive information security program that protects consumers' financial assets. The order explicitly ties the Security Program to protecting users' funds.
Regular security audits and truthful assessments for 10 years
Part III requires Illusory Systems to obtain an initial and then biennial (every two years) data security assessment for ten years. Part IV requires full disclosure of material facts to the assessor and forbids misrepresenting facts material to those assessments.
Ban on false security and asset claims
Part I of the proposed order prohibits the company from misrepresenting how much it implements reasonable software development practices and how well it secures consumers' financial assets. This stops the company from making deceptive claims about security.
Ongoing compliance reporting and 10-year duration
The order requires annual senior-manager certifications, compliance reports, recordkeeping, and notifications about bankruptcy or structural changes. With exceptions, the order will terminate in 10 years. These steps create ongoing monitoring of the company's conduct.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-16827, Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
The Federal Trade Commission (FTC or Commission) requests that the Office of Management and Budget (OMB) extend for three years the current Paperwork Reduction Act (PRA) clearance for its Trade Regulation Rule on Disclosure Requirements and Prohibitions Concerning Franchising (Franchise Rule or Rule). The current clearance expires on August 31, 2026.
2026-16617, Regulatory Agenda
The Federal Trade Commission (FTC or Commission) is publishing its regulatory agenda in accordance with section 22(d)(1) of the Federal Trade Commission Act, 15 U.S.C. 57b-3(d)(1) and the Regulatory Flexibility Act (RFA), 5 U.S.C. 601 to 612, as amended by the Small Business Regulatory Enforcement Fairness Act. The Commission's agenda follows guidelines and procedures issued September 15, 2025, by the Office of Management and Budget in accordance with the provisions of Executive Order 12866, "Regulatory Planning and Review," 58 FR 51735 (Oct. 4, 1993) and Executive Order 14192, "Unleashing Prosperity Through Deregulation," 90 FR 9065 (Feb. 6, 2025). The Government-wide Unified Agenda of Federal Regulatory and Deregulatory Actions includes a list of all regulatory actions under development or review and is scheduled for publication in its entirety on www.reginfo.gov and www.regulations.gov in a format that offers users a greatly enhanced ability to obtain information from the agenda database. The RFA requires publication in the Federal Register of agenda entries for rules that are likely to have a significant impact on a substantial number of small entities (5 U.S.C. 602) and any such rules that the agency has identified for periodic review under section 610 of the RFA. For the 2026 agenda, the Commission has no rule that meets the RFA's publication requirements. The Commission has identified rulemakings that are likely to have some impact on small entities, but do not meet the RFA's publication requirements. The current rulemakings that are likely to have some impact on small entities are: (1) the Energy Labeling Rule, 16 CFR 305; (2) the Alternative Fuel Rule, 16 CFR 309; (3) the removal of the vacated 2024 amendments to the Negative Option Rule, 16 CFR 425; (4) the Cooling-Off Rule, 16 CFR 429; (5) the Amplifier Rule, 16 CFR 432; (6) the Business Opportunity Rule, 16 CFR 437; (7) the Impersonation Rule, 16 CFR 461; (8) the withdrawal of the final rule for the vacated Combating Auto Retail Scams Rule (16 CFR 463); (9) the proposed Earnings Claims Trade Regulation Rule, to be codified at 16 CFR 462; (10) Unfair or Deceptive Fees Trade Regulation Rule, 16 CFR 464; and (11) the removal of the vacated Non-Compete Clause Rule from 16 CFR 910. The Commission's rulemaking review process carefully considers regulatory burdens and streamlines rules when feasible and appropriate. The majority of the rulemakings listed in the agenda are being conducted as part of the Commission's systematic review of all of its regulations and guides on a rotating basis. Under the Commission's program, rules are reviewed on a 10-year schedule. In each rule review, the Commission requests public comments on, among other things, the economic impact and benefits of the rule; possible conflict between the rule and state, local, or other federal laws or regulations; and the effect on the rule of any technological, economic, or other industry changes. These reviews incorporate and expand upon the review required by the RFA and regulatory reform initiatives directing agencies to conduct a review of all regulations and eliminate or revise those that are outdated or otherwise in need of reform. Except for notice of completed actions, the information in this agenda represents the judgment of Commission staff, based upon information now available. Each projected date of action reflects FTC staff's assessment that the specified event will occur this year. No final determination by the staff or the Commission respecting the need for or the substance of a rule should be inferred from the notation of projected events in this agenda. In most instances, the dates of future events are listed by month, not by a specific day. The information in this agenda may change as new information, changes of circumstances, or changes in the law occur.
2026-15955, Privacy Act of 1974; System of Records
The FTC proposes to modify its Privacy Act system of records notices (SORNs) by adding a routine use to four specific SORNs to comply with Executive Order 14249, Protecting America's Bank Account Against Fraud, Waste, and Abuse, and OMB Memorandum M-25-32, Preventing Improper Payments and Protecting Privacy Through Do Not Pay. The FTC is also separately making technical changes to three of these SORNs.
2026-15913, Caremark and Zinc Health Services; Analysis of Proposed Agreement Containing Consent Order To Aid Public Comment
The consent agreement in this matter settles alleged violations of Federal law prohibiting unfair methods of competition. The attached Analysis of Proposed Agreement Containing Consent Orders to Aid Public Comment describes both the allegations in the complaint and the terms of the consent order--embodied in the consent agreement-- that would settle these allegations.
2026-15182, Petition for Rulemaking of the National Consumers League, Campaign for Fairer Gambling, the National Council for Problem Gambling, the Public Health Advocacy Institute, and Truth in Advertising, Inc.
Please take notice that the Federal Trade Commission ("Commission") received a petition for rulemaking from the National Consumers League, Campaign for Fairer Gambling, the National Council for Problem Gambling, the Public Health Advocacy Institute, and Truth in Advertising, Inc., and has published that petition online at https://www.regulations.gov. The Commission invites written comments concerning the petition. Publication of this petition is pursuant to the Commission's Rules of Practice and Procedure and does not affect the legal status of the petition or its final disposition.
2026-14920, Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
The Federal Trade Commission wants to keep its rules for how gas stations and fuel sellers measure and share fuel quality for three more years. This affects refiners, importers, distributors, and retailers who must keep records and share fuel ratings. Comments on this plan are open until September 21, 2026, and the paperwork costs about $455,000 a year in labor.
Previous / Next Documents
Previous: 2025-23406, Limitation on Claims Against Proposed Public Transportation Projects-West Broad Street Bus Rapid Transit, Columbus, Franklin County, Ohio and VIA Advanced Rapid Transit East/West Corridor Project, San Antonio, Bexar County, Texas
The Federal Transit Administration has given the green light to two big public transit projects: a new bus rapid transit line in Columbus, Ohio, and an advanced rapid transit corridor in San Antonio, Texas. If anyone wants to challenge these decisions, they must file a claim by May 18, 2026, or lose their chance. These projects are moving forward with environmental approvals, paving the way for better transit and smoother commutes!
Next: 2025-23408, Determination That EFFEXOR XR (Venlafaxine Hydrochloride) Extended-Release Capsule, 100 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that EFFEXOR XR 100 mg capsules were not taken off the market because of safety or effectiveness problems. This means generic drug makers can keep getting approval to sell their versions of this medicine, helping patients access affordable options. No changes in safety rules or costs are expected, so things stay steady for doctors, patients, and pharmacies.